TrialCephalalgia : an international journal of headache2021

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study.

Shuu-Jiun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.